GLAND · Healthcare
The board meets on 6 Nov 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,373 cr | ₹1,545 cr | ₹1,537 cr | ₹1,402 cr | ₹1,406 cr | ₹1,384 cr | ₹1,425 cr | ₹1,506 cr | ₹1,487 cr | ₹1,695 cr | ₹1,743 cr | ₹1,800 cr |
| YoY | — | — | — | +16% | +2% | −10% | −7% | +7% | +6% | +22% | +22% | +20% |
| EBITDA margin | 23.6% | 23.0% | 23.4% | 18.8% | 21.1% | 26.0% | 24.4% | 24.4% | 21.1% | 25.7% | 29.4% | 27.2% |
| Other income, % of PBT | 18% | 13% | 14% | 23% | 23% | 19% | 15% | 19% | 30% | 11% | 22% | 14% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 33% | 32% | 35% | 34% | 36% | 32% | 35% | 31% | 35% | 28% | 28% | 27% |
| Net profit | ₹194 cr | ₹192 cr | ₹192 cr | ₹144 cr | ₹164 cr | ₹205 cr | ₹187 cr | ₹215 cr | ₹184 cr | ₹261 cr | ₹367 cr | ₹317 cr |
| YoY | — | — | — | −26% | −15% | +7% | −3% | +49% | +12% | +27% | +96% | +47% |
| Core profit YoY | — | — | — | −25% | −17% | −2% | −5% | +53% | +2% | +34% | +62% | +47% |
| EPS | ₹11.78 | ₹11.65 | ₹11.68 | ₹8.73 | ₹9.93 | ₹12.42 | ₹11.32 | ₹13.08 | ₹11.15 | ₹15.87 | ₹22.26 | ₹19.21 |
| Flags | · | · | · | 1 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 1 | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.